Join us for a talk by MD Kabir, PhD, a postdoctoral fellow in the Jian lab, as he shares his journey from fundamental discovery to therapeutic innovation. Dr. Kabir will present his work on multispecific nanobody degraders—a novel platform for targeted membrane receptor depletion and payload delivery—and discuss how his team is working to translate this academic research into intellectual property with commercial potential. This seminar highlights the evolving role of early-career scientists in bridging academic research and entrepreneurial biotech, showcasing strategies for moving from bench science to asset development in the competitive landscape of targeted therapeutics.